Q94

N-{5-[(3R)-3-{[5-(acetylamino)-1,3,4-thiadiazol-2-yl]amino}pyrrolidin-1-yl]-1,3,4-thiadiazol-2-yl}acetamide

Created:	2019-10-04
Last modified:	2020-10-07

Find Related PDB Entry
1 entries where Q94 is found as a standalone ligand

Find related ligands:

Similar Ligands (Stereospecific) Similar Ligands (including Stereoisomers) Similar Ligands (Quick Screen) Similar Ligands (Substructure Stereospecific) Similar Ligands (Substructure including Stereoisomers)

Chemical Details
Formal Charge	0
Atom Count	40
Chiral Atom Count	1
Bond Count	42
Aromatic Bond Count	10

2D diagram of Q94

Toggle Hydrogen Toggle Labels

Chemical Component Summary
Name	N-{5-[(3R)-3-{[5-(acetylamino)-1,3,4-thiadiazol-2-yl]amino}pyrrolidin-1-yl]-1,3,4-thiadiazol-2-yl}acetamide
Systematic Name (OpenEye OEToolkits)	~{N}-[5-[[(3~{R})-1-(5-acetamido-1,3,4-thiadiazol-2-yl)pyrrolidin-3-yl]amino]-1,3,4-thiadiazol-2-yl]ethanamide
Formula	C₁₂ H₁₆ N₈ O₂ S₂
Molecular Weight	368.438
Type	NON-POLYMER

Chemical Descriptors
Type	Program	Version	Descriptor
SMILES	ACDLabs	12.01	c3(N1CCC(C1)Nc2nnc(NC(C)=O)s2)sc(nn3)NC(C)=O
SMILES	CACTVS	3.385	CC(=O)Nc1sc(N[CH]2CCN(C2)c3sc(NC(C)=O)nn3)nn1
SMILES	OpenEye OEToolkits	2.0.7	CC(=O)Nc1nnc(s1)NC2CCN(C2)c3nnc(s3)NC(=O)C
Canonical SMILES	CACTVS	3.385	CC(=O)Nc1sc(N[C@@H]2CCN(C2)c3sc(NC(C)=O)nn3)nn1
Canonical SMILES	OpenEye OEToolkits	2.0.7	CC(=O)Nc1nnc(s1)N[C@@H]2CCN(C2)c3nnc(s3)NC(=O)C
InChI	InChI	1.03	InChI=1S/C12H16N8O2S2/c1-6(21)13-9-16-17-11(23-9)15-8-3-4-20(5-8)12-19-18-10(24-12)14-7(2)22/h8H,3-5H2,1-2H3,(H,15,17)(H,13,16,21)(H,14,18,22)/t8-/m1/s1
InChIKey	InChI	1.03	YVDVVIJXVARLFM-MRVPVSSYSA-N

Related Resource References

Resource Name	Reference
Pharos	CHEMBL3769558
PubChem	121256446
ChEMBL	CHEMBL3769558

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.